NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Diamidex

Diamidex

Private
MarseilleFrontier & Industrial Techhttps://diamidex.com/

Last Round

Crowdfunding

Jun 2, 2025

Est. Valuation

$16.15M

Total Funding Raised

$3.11M

Company Overview

Diamidex is a biotechnology company that develops, manufactures, and sells a range of innovative solutions, including equipment, software, and reagents, to detect and count targeted microorganisms.

Sector

Frontier & Industrial Tech

Verticals

Biotech Equipment, Quality Management, Environmental Monitoring, Computer Vision

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

rapid microbiological analysisautomated colony countermicroorganism detectionwater safety testingmachine learning image analysisLegionella detectionproprietary consumablesfood safety testingenvironmental monitoringbiotech equipmentreagent kitscomputer visionculture-based testingTotal Viable CountTVCE. coli detectionpharmaceutical testing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Diamidex Comparables

Compare Diamidex with similar companies based on industry and business-model similarity.

Diamidex comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Diamidex Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingJun 2, 2025
GrantMay 21, 2024
VC RoundNov 8, 2023
VC RoundOct 2, 2019

Key People

Founding team and executive leadership

Sam Dukan

CEO DIAMIDEX

Executive Team

Diamidex Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 19, 2026

    Grew 25% QoQ from 28 to 35 employees.

  • Jan 1, 2026

    Monthly visitors grew 148% MoM, reaching 1.1K.

Diamidex Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Diamidex Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Diamidex's valuation, stock price, and market status.

Firmographic Details

HeadquartersMarseille
Employee Range34
Year Founded2014
Last FundingJun 2, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.